Professor Pavel Klener is a hematologist specializing in the treatment and research of non-Hodgkin lymphomas, with a particular focus on mantle cell lymphoma. He serves as principal investigator and co-investigator of numerous grants in translational lymphoma research, including experimental therapeutic approaches, mechanisms of drug resistance, mutational profiling, and clonal evolution. He is a frequent speaker at both national and international conferences and is the author or co-author of more than 110 publications in peer-reviewed journals with an impact factor.
